|
Osteonecrosis of the Jaw Resources
1. American Dental Association Update
2. Woo S-B, Hande K, Richardson PG.
Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:100
3. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL.
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34
4. Expert Panel Recommendations for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaws: June 2004 PDF file/56k
5. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S-B.
Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper. JADA 2005;136:1658-68
6. ADA Council on Scientific Affairs. Expert Panel Recommendations: Dental Management of Patients on Oral Bisphosphonate Therapy. June 2006. PDF file/78k
7. Ott SM.
Long-term safety of bisphosphonates. J Clin Endocrinol Metab 2005;90:1897-9.
8.
Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V.
Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer. J Oncol Prac 2006;2:7-14 PDF File/282k
PDF files
=======
Obtaining Informed Consent Relating to Risks Associated with Oral Bisphosphonate Use - PDF file/27k
List of Bisphosphonates
=================
Actonel
Alendronate
Aredia
Bonefos
Boniva
Clodronate
Didronel
Etidronate
Fosamax
Fosamax Plus D
Ibandronate
Pamidronate
Risedronate
Skelid
Tiludronate
Zolendronic Acid
Zometa
|